CDC14B and neoplasm: Interestingly, genes with oncogenic potential, including CDC42, CDC14B, STK40, BRD3, CPNE1, and MCM3, were downregulated, whereas tumor inhibitors, including CDKN2C, CASP7, and CDKN1B, were upregulated by RBM15 depletion (Fig. 3a).